https://www.neurorohan.com/news-1/ozempic-for-the-brain%3F-inside-semaglutide%E2%80%99s-ambitious-and-paused-alzheimer%E2%80%99s-trial 2025-12-30 https://www.neurorohan.com/news-1/eli-lilly's-%2427-billion-u.s.-investment%3A-a-game-changer%3F 2025-12-24 https://www.neurorohan.com/news-1/new-insights-into-alzheimer%E2%80%99s-disease-detection-with-blood-biomarkers 2025-12-24 https://www.neurorohan.com/news-1/new-findings-on-sex-differences-in-alzheimer's-disease-progression! 2025-12-24 https://www.neurorohan.com/news-1/eu-rejects-lilly's-alzheimer's-treatment%2C-kisunla-(donanemab) 2025-12-24 https://www.neurorohan.com/news-1/brains-in-crisis%3A-neurological-conditions-become-the-world's-leading-health-burden 2025-12-24 https://www.neurorohan.com/news-1/long-term-leqembi%C2%AE-treatment-slows-alzheimer%E2%80%99s-disease-progression-%E2%80%93-a-hope-for-longevity! 2025-12-30